Clinical Trials
34 trialsProof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
H. Lee Moffitt Cancer Center and Research Institute
PALANGI3
Centre Oscar Lambret
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Emory University
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Massachusetts Eye and Ear Infirmary
HAITILS
Vastra Gotaland Region
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
HonorHealth Research Institute
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
Memorial Sloan Kettering Cancer Center
SCANDIUM II
Vastra Gotaland Region
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
University of Michigan Rogel Cancer Center
Vaccine Therapy in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
TIMAR1
Perspective Therapeutics
Intermittent Selumetinib for Uveal Melanoma
Columbia University
Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Columbia University
CLEVER
Viralytics
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
Hoffmann-La Roche
A Study of PLX2853 in Advanced Malignancies.
Opna Bio LLC
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Pfizer
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Incyte Corporation
Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Novartis
Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Iconic Therapeutics, Inc.
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Jonsson Comprehensive Cancer Center
Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
Centre Hospitalier Universitaire Vaudois
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
University of Pittsburgh
Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
Memorial Sloan Kettering Cancer Center
Mel48
University of Virginia
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Massachusetts Eye and Ear Infirmary
Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Polaris Group
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery
University of Southern California
Dendritic Cell Vaccination During Lymphoid Reconstruction
H. Lee Moffitt Cancer Center and Research Institute
Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
The New York Eye Cancer Center
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation
Ichor Medical Systems Incorporated